NASDAQ · PPH
VanEck Pharmaceutical ETF
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
Loading market information…
NASDAQ · RAA · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
SMI 3Fourteen REAL Asset Allocation ETF’s quoted price sits in the upper half of its reported 52-week range, 2.72% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SMI 3Fourteen REAL Asset Allocation ETF’s forward annual dividend is $0.50 per share, paid quarterly. The forward yield is 1.67% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
ETF Opportunities Trust - SMI 3Fourteen REAL Asset Allocation ETF is an exchange traded fund launched by ETF Opportunities Trust. The fund is co-managed by 3Fourteen & SMI Advisory Services, LLC and ETF Opportunities Trust. It invests in public equity, fixed income markets, commodity and currency markets. For its equity portion, it invests in stocks of companies operating across diversified sectors. It invests in volatility stocks of companies across diversified market capitalization. For its fixed income portion, it invests in fixed income securities such as bonds and cash and cash equivalents. For its commodity portion, it invests in commodity markets. For its currency portion, it invests in cryptocurrency. The fund employs proprietary research to create its portfolio. ETF Opportunities Trust - SMI 3Fourteen REAL Asset Allocation ETF February 26, 2025 and is domiciled in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 11:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$269.36-$5.94 (-2.16%)
Inspire 500 ETF’s quoted price sits in the upper half of its reported 52-week range, 8.14% below the high.
$34.51-$0.26 (-0.75%)
Innovator U.S. Equity 10 Buffer ETF - Quarterly’s quoted price sits in the upper half of its reported 52-week range, 0.98% below the high.
$246.64-$1.82 (-0.73%)
State Street SPDR S&P 1500 Value Tilt ETF’s quoted price sits in the upper half of its reported 52-week range, 1.73% below the high.
$66.71-$0.57 (-0.84%)
Longview Advantage ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$55.91-$1.06 (-1.85%)
Strategy Shares Day Hagan Smart Sector ETF’s quoted price sits in the upper half of its reported 52-week range, 2.57% below the high.
$64.86-$3.55 (-5.19%)
Sprott Gold Miners ETF’s quoted price sits in the lower half of its reported 52-week range, 32.79% below the high.
$21.56-$0.16 (-0.74%)
RPAR Risk Parity ETF’s quoted price sits in the lower half of its reported 52-week range, 8.99% below the high.
